Stratos Wealth Partners LTD. Sells 12,580 Shares of CVS Health Corporation (NYSE:CVS)

Stratos Wealth Partners LTD. cut its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 31.7% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,077 shares of the pharmacy operator's stock after selling 12,580 shares during the period. Stratos Wealth Partners LTD.'s holdings in CVS Health were worth $1,834,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Essex Financial Services Inc. increased its holdings in CVS Health by 0.8% in the 1st quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator's stock valued at $1,403,000 after buying an additional 166 shares during the period. McIlrath & Eck LLC boosted its position in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after acquiring an additional 174 shares in the last quarter. Koshinski Asset Management Inc. increased its stake in CVS Health by 3.7% in the first quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator's stock valued at $334,000 after acquiring an additional 178 shares during the period. Horizon Bancorp Inc. IN boosted its holdings in CVS Health by 7.4% during the first quarter. Horizon Bancorp Inc. IN now owns 2,610 shares of the pharmacy operator's stock valued at $177,000 after purchasing an additional 180 shares in the last quarter. Finally, Coppell Advisory Solutions LLC grew its stake in shares of CVS Health by 17.3% in the 4th quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock valued at $56,000 after purchasing an additional 189 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

Insider Buying and Selling at CVS Health

In related news, Director Guy P. Sansone acquired 1,570 shares of the firm's stock in a transaction on Thursday, June 5th. The shares were purchased at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the acquisition, the director directly owned 12,007 shares in the company, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 1.22% of the company's stock.

Wall Street Analyst Weigh In

CVS has been the topic of several recent analyst reports. Jefferies Financial Group boosted their price target on CVS Health from $74.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Truist Financial increased their target price on shares of CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Monday, May 12th. Barclays set a $79.00 price target on shares of CVS Health and gave the company an "overweight" rating in a research report on Monday, June 2nd. Morgan Stanley reaffirmed an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Finally, Royal Bank Of Canada boosted their target price on CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, CVS Health currently has an average rating of "Moderate Buy" and an average price target of $75.06.

CVS Health Stock Down 1.4%

NYSE:CVS traded down $0.89 during trading hours on Friday, reaching $64.73. 7,020,831 shares of the stock were exchanged, compared to its average volume of 10,796,063. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51. The stock has a market cap of $81.88 billion, a PE ratio of 15.45, a PEG ratio of 0.94 and a beta of 0.57. The firm has a 50 day moving average of $65.05 and a 200 day moving average of $62.22.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The business's revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.31 EPS. On average, equities analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd will be paid a dividend of $0.665 per share. The ex-dividend date is Tuesday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.11%. CVS Health's dividend payout ratio is currently 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.